Bearish
Cash runway, pipeline and going concern at IN8bio (NASDAQ: INAB)
IN8bio (NASDAQ: INAB) reported a Q1 2026 net loss of $5.1 million, an improvement from the $5.6 million loss in Q1 2025. The company's cash balance of...